EpoTheta-Teva 1000
EpoTheta-Teva 1000 is a medicine authorised by Swissmedic under authorisation number 59636. The authorisation holder is Teva Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 November 2010 and the authorisation is valid without a time limit. ATC code B03XA01 places the medicine in the group Antianemic preparations.
| Authorisation number | 59636 |
|---|---|
| Name | EpoTheta-Teva 1000 |
| Full name | EpoTheta-Teva 1000, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | B03XA01 |
| First authorisation | 24 November 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | EpoTheta-Teva 1000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 2 | EpoTheta-Teva 2000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 3 | EpoTheta-Teva 3000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 4 | EpoTheta-Teva 4000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 5 | EpoTheta-Teva 5000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 6 | EpoTheta-Teva 10'000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 7 | EpoTheta-Teva 20'000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
| 8 | EpoTheta-Teva 30'000, Injektionslösung in einer Fertigspritze | A | 24 November 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 29 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 31 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 33 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 35 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 37 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 39 | 1 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 41 | 4 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 43 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 45 | 1 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 47 | 4 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 49 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 51 | 1 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 53 | 4 | Spritze(n) | B03XA01 | 06.07.3. | A |
| 55 | 6 | Spritze(n) | B03XA01 | 06.07.3. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is EpoTheta-Teva 1000 authorised in Switzerland?
Yes. EpoTheta-Teva 1000 is authorised by Swissmedic under authorisation number 59636, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does EpoTheta-Teva 1000 have?
EpoTheta-Teva 1000 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of EpoTheta-Teva 1000?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.